National Views on Guidance Documents for NCVR (costing industry-sponsored clinical research)
Date: 24 April 2026
This survey aims to gather national perspectives on guidance documents related to costing industry-sponsored clinical research studies. We want to hear from everyone involved in costing commercial research on what good costing guidance should look like to allow R&D staff to all adhere to national NCVR principles and importantly support us to all cost the same way, with improved timelines, clarity and consistency, providing education and a clear and definitive position when needed.
The survey is anonymous and open to NHS and non-NHS (such as pharma sponsor, CRO etc) respondents. The survey will close on Monday 4th May at 5pm. Complete the survey here.